Antares Pharma Inc - ESG Rating & Company Profile powered by AI
This webpage contains a free ESG assessment covering Antares Pharma Inc. The Disclosure rating includes seventeen UN SDGs including: 'Good Health & Wellbeing', 'Climate Action' and 'Life below Water'. Jump to the end of the webpage for potential risks for Antares Pharma Inc based on sector, geography and size.
Antares Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 1.6, social score of 2.7 and governance score of 6.4.
3.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
| 1132 | Traphaco JSC | 3.7 | Medium |
| 1144 | Antares Pharma Inc | 3.6 | Medium |
| 1144 | CellSeed Inc | 3.6 | Medium |
| 1144 | Cellectar Biosciences Inc | 3.6 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Antares Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Antares Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Antares Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Antares Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Antares Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Antares Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Antares Pharma Inc offer flexible work?
Sign up for free to unlockDoes Antares Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Antares Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Antares Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Antares Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Antares Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Antares Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Antares Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Antares Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Antares Pharma Inc disclose water use targets?
Sign up for free to unlockDoes Antares Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Antares Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Antares Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Antares Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Antares Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Antares Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Antares Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Antares Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Antares Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Antares Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Antares Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Antares Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Antares Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Antares Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Antares Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes Antares Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Antares Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Antares Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes Antares Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Antares Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Antares Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas. It develops, manufactures, and commercialize novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and for glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto injectors; and drug/device product for urologic oncology and endocrinology. The company have strategic alliances and partnership arrangements pharmaceutical companies, including Pfizer, Idorsia, Teva, and AMAG. Antares Pharma, Inc. was founded in 1978 and is headquartered in Ewing, New Jersey.